Form 4: Surrozen COO Boosts Stake via Employee Stock Plan

Surrozen, Inc.'s Chief Operating Officer, Charles O Williams, acquired 1,666 shares of common stock at $8.11 per share through the company's 2021 Employee Stock Purchase Plan.

Summary

• Charles O Williams, Chief Operating Officer of Surrozen, Inc. (SRZN), acquired 1,666 shares of common stock.
• The transaction occurred on December 15, 2025, at a price of $8.11 per share.
• Following this acquisition, Mr. Williams beneficially owns 11,048 shares of Surrozen common stock.
• The shares were acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan (ESPP).
• The transaction is exempt under SEC Rules 16b-3(d) and 16b-3(c).

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive through an ESPP is a positive signal of confidence and alignment of interests, though it's a routine transaction rather than a discretionary open-market purchase.

Positives

• Increased beneficial ownership by a key executive (Chief Operating Officer) signals confidence in the company's future prospects.
• Participation in the Employee Stock Purchase Plan demonstrates alignment of management's interests with those of shareholders.

Negatives

• No negative aspects are indicated in this Form 4 filing.

Risks

• This filing does not contain information regarding specific risks.

Future Outlook

This filing, an insider transaction report, does not provide forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• This reporting person is voluntarily reporting these shares acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Industry Context

Insider purchases, particularly through employee stock plans, are common in the biotechnology and pharmaceutical sectors. They generally indicate management's belief in the company's long-term value, aligning executive interests with shareholder returns. This transaction is a routine part of an employee benefit program.

Comparison to Industry Standards

• Employee Stock Purchase Plans (ESPPs) are a standard benefit offered by many public companies, including those in the biotech industry, to encourage employee ownership and align interests.
• The acquisition of shares by a Chief Operating Officer through an ESPP is a common occurrence and is generally viewed as a positive signal of management's commitment, consistent with practices at comparable companies.

Related Party Transactions

• The acquisition of shares by the Chief Operating Officer through the company's Employee Stock Purchase Plan is a transaction between a related party (executive) and the issuer, conducted under a pre-approved employee benefit program.

Stakeholder Impact

• Shareholders: Increased insider ownership can be viewed positively, suggesting management's belief in the company's future and aligning their financial interests with those of other shareholders.
• Employees: The transaction highlights the availability and utilization of the company's Employee Stock Purchase Plan, which is a benefit for eligible employees.

Next Steps

• No specific future actions or milestones are mentioned in this Form 4 filing.

Key Dates

Keywords

Surrozen, SRZN, Form 4, Insider Transaction, Employee Stock Purchase Plan, ESPP, Charles O Williams, Common Stock Acquisition, Officer Stock Purchase